Arkolith/Insider Trading/AUPH/Form 4

Donley Matthew Maxwell

Chief Operating OfficerAurinia Pharmaceuticals Inc. (AUPH) · full profile →Form 4 · filed Mar 4, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$994K
Net Open-Market Flow
-$994K
Transactions
5
4 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 4, 2025Sell(S)59K$7.92$467K680K
Mar 3, 2025Sell(S)66K$8.00$527K739K
Mar 3, 2025Grant(A)136K—$0805K
Feb 28, 2025Grant(A)83K—$0670K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 28, 2025Grant(A)126K—$0126K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001600620-25-000018) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML